Navigation Links
Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events
Date:5/13/2013

DUBLIN, May 13, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will participate in three upcoming investor events. A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. The events, presentation times and speakers include:

  • UBS Global Healthcare Conference in New York, NY on Tuesday, May 21, 2013 at 9:30 a.m. EDT/2:30 p.m. IST. Kathryn E. Falberg , executive vice president and chief financial officer, will provide a business update.
  • Jefferies 2013 Global Healthcare Conference in New York, NY on Tuesday, June 4, 2013 at 8:30 a.m. EDT/1:30 p.m. IST. Bruce C. Cozadd , chairman and chief executive officer, will provide a business update.
  • Lazard Capital Markets Conference Call at the 27th Annual Meeting of the American Academy of Sleep Medicine in Baltimore, MD on Wednesday, June 5, 2013 at 12:30 p.m. EDT/5:30 p.m. IST. Company management will discuss data being presented, including findings from the Burden of Narcolepsy Disease (BOND) study, and other business matters.

An archived version of each audio webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion and FazaClo® (clozapine, USP) HD. Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its EUSA Pharma division. For further information, see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
2. Arbor Pharmaceuticals Announces FDA Approval of First NDA
3. Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer
4. Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of Shareholders
5. Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
6. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
7. Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance Proposal
8. Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
9. The Zacks Analyst Blog Highlights: Exxon Mobil, Statoil, Chevron, Braskem and Cubist Pharmaceuticals
10. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... India , February 11, 2016 ... Global Autoclave Market Report 2016 research report provides ... key regions, development status with crucial statistical data ... --> http://www.deepresearchreports.com/142870.html . --> Complete ... profiling 19 companies and supported with 296 tables ...
(Date:2/10/2016)... Feb. 11, 2016  QT Vascular Ltd., together with ... together with its subsidiaries, the "Group"), is pleased ... with AngioScore, Inc. ("ÄngioScore") (now owned by Spectranetics ... the United States Court of ... reversed an earlier district court order (the "DCO").   ...
(Date:2/10/2016)... Inc. (Nasdaq: GHDX ) today reported financial results and ... --> --> Revenue was $74.5 ... in the fourth quarter of 2014, an increase of 8 percent. ... the same period in the prior year. --> ... fourth quarter of 2015, an increase of 9 percent compared with ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... The annual list showcases ... evaluation of DataPoint’s team dedication and commitment to the SharePoint ecosystem. A ... annual list. The panel’s goal is to recognize and promote technology entrepreneurship. , ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Be ... new office in the heart of Old Town at 108 South Columbus St, Suite ... businesses the highest level of medical care in the convenience of their homes, offices ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hoggan ... force gauges used in physical therapy, occupational therapy and sports medicine clinics, hospitals, ... cord exercise and therapy, introduces its new microFET Digital Pinch Gauge. , ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... become more actively engaged in health and wellness best practices in the past ... riding this trend. February is American Heart Month, which acts as an exceptional ...
(Date:2/11/2016)... ... February 11, 2016 , ... Research led by Providence ... several common cancer screenings, especially among women. Cancer screenings are often the best ... , The study,“What Does Medicaid Expansion Mean for Cancer Screening and Prevention: Results ...
Breaking Medicine News(10 mins):